Shankar Iyer - Intertrust CEO Board

Insider

Shankar Iyer is CEO Board of Intertrust NV
Age 59
Phone31 20 521 4777
Webhttps://www.intertrustgroup.com

Intertrust Management Efficiency

The company has return on total asset (ROA) of 0.0294 % which means that it generated a profit of $0.0294 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0339 %, meaning that it generated $0.0339 on every $100 dollars invested by stockholders. Intertrust's management efficiency ratios could be used to measure how well Intertrust manages its routine affairs as well as how well it operates its assets and liabilities.
Intertrust NV has accumulated 1.02 B in total debt with debt to equity ratio (D/E) of 1.12, which is about average as compared to similar companies. Intertrust NV has a current ratio of 1.2, suggesting that it may not be capable to disburse its financial obligations in time and when they become due. Debt can assist Intertrust until it has trouble settling it off, either with new capital or with free cash flow. So, Intertrust's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intertrust NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intertrust to invest in growth at high rates of return. When we think about Intertrust's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

JeanChristophe MarcouxGenfit
47
Thomas BaetzGenfit
51
BSRT MPHRadNet Inc
N/A
Siew MSAcumen Pharmaceuticals
N/A
John KnorppMerit Medical Systems
N/A
Quinn DeverauxInhibrx
N/A
Pascal CaiseyGenfit
56
Michel VoigtMerit Medical Systems
52
CPA ParraMerit Medical Systems
47
Ruth VilligerWilsonRadNet Inc
60
BS CPAInhibrx
42
Stefanie MagnerGenfit
43
Julie BockenstetteAcumen Pharmaceuticals
N/A
Pr StaelsGenfit
62
Eric MDAcumen Pharmaceuticals
69
Ranjan JayanathanRadNet Inc
68
Russell MSAcumen Pharmaceuticals
67
Janice HitchcockAcumen Pharmaceuticals
N/A
Liean MSAcumen Pharmaceuticals
N/A
Joseph PierceMerit Medical Systems
N/A
Nicole PriestMerit Medical Systems
N/A
Intertrust N.V. provides corporate, fund, capital market, and private wealth services in Western Europe, the Americas, and internationally. Intertrust N.V. was incorporated in 1952 and is headquartered in Amsterdam, the Netherlands. Intertrust is traded on OTC Exchange in the United States. Intertrust NV [ITRUF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Intertrust NV Leadership Team

Elected by the shareholders, the Intertrust's board of directors comprises two types of representatives: Intertrust inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intertrust. The board's role is to monitor Intertrust's management team and ensure that shareholders' interests are well served. Intertrust's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intertrust's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rogier Wijk, CFO Board
Corneel Ryde, G Counsel
Ian Rumens, Global Wealth
Cliff Pearce, Global Markets
Shankar Iyer, CEO Board
Daniel Jaffe, Managing World
Marie McNeela, Managing Guernsey
Ian Lynch, Chief Officer
Roberto Canenti, Chief Officer
Marieke Palstra, Marketing Relations

Intertrust Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Intertrust a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Consideration for investing in Intertrust OTC Stock

If you are still planning to invest in Intertrust NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intertrust's history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fundamental Analysis
View fundamental data based on most recent published financial statements